ACE inhibitor use delays development of renal involvement in patients with systemic lupus erythematosus (SLE). In a study of 378 SLE patients, 80 (21%) were ACE inhibitor users and 298 (79%) were not.
Please provide your email address to receive an email when new articles are posted on . There was a significant independent link between angiotensin-converting enzyme inhibitor use and all-cause ...
Treatment with an angiotensin-converting enzyme (ACE) inhibitor/angiotensin receptor blocker and sodium-glucose cotransporter-2 (SGLT2) inhibitor combination demonstrated better outcomes in kidney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results